EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 2.2cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200°C to 300°C (392°F to 572°F).
|
307-757-9
|
97722-08-2
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons produced by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164°C to minus 0.5°C (-263°F to 31°F).
|
271-032-2
|
68514-31-8
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately -164°C to -0.5°C(-263°F to 31°F).
|
271-038-5
|
68514-36-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
271-261-8
|
68527-19-5
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | |||
|
A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164°C to minus 42°C (-263°F to -44°F).
|
271-259-7
|
68527-16-2
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by solvent extraction from a naphthenic distillate having a viscosity of 27cSt at 100°C (212°F). It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C26 through C55 and boiling in the range of approximately 395°C to 640°C (743°F to 1184°F).
|
307-753-7
|
97722-04-8
|
Carc. 1B |
Details | ||
|
The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).
|
309-749-0
|
100801-66-9
|
Carc. 1B; Muta. 1B |
Details | ||
|
The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).
|
309-748-5
|
100801-65-8
|
Carc. 1B; Muta. 1B |
Details | ||
|
The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).
|
309-745-9
|
100801-63-6
|
Carc. 1B; Muta. 1B |
Details | ||
|
233-113-0
|
10035-10-6
|
Press. Gas; Skin Corr. 1A; STOT SE 3 |
Details | |||
|
233-113-0
|
10035-10-6
|
Skin Corr. 1B; STOT SE 3 |
Details | |||
|
233-109-9
|
10034-85-2
|
Skin Corr. 1B |
Details | |||
|
233-109-9
|
10034-85-2
|
Press. Gas; Skin Corr. 1A |
Details | |||
|
204-563-5
|
122-66-7
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
-
|
14913-74-7
|
Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
Details | |||
|
616-584-0
|
7803-57-8
|
C Carcinogenic (article 57a) |
Details | |||
|
STABO-FIX
|
405-030-1
|
148434-03-1
|
Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
C Carcinogenic (article 57a) |
Details | ||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
Details | |||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
Acute Tox. 4; Eye Dam. 1 |
Details | ||
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
Skin Sens. 1 |
Details | ||
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
Resp. Sens. 1; Skin Sens. 1 |
Details | ||
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
Eye Dam. 1 |
Details | ||
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
Eye Irrit. 2 |
Details | ||
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
Details | |||
|
-
|
-
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
Details | |||
|
209-731-1
|
591-78-6
|
Flam. Liq. 3; Repr. 2; STOT RE 1; STOT SE 3 |
Details | |||
|
203-852-3
|
111-27-3
|
Acute Tox. 4 |
Details | |||
|
211-653-8
|
680-31-9
|
Carc. 1B; Muta. 1B |
Details | |||
|
204-679-6
|
124-09-4
|
Acute Tox. 4; STOT SE 3; Skin Corr. 1B |
Details | |||
|
212-485-8
|
822-06-0
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
235-921-9
|
13048-33-4
|
Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
DIRECT RED 227, TETRAMETHYLAMMONIUM SALT
|
405-160-9
|
124537-30-0
|
Acute Tox. 3; Skin Sens. 1 |
Details | ||
|
247-094-1
|
25550-51-0
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
RSP Respiratory sensitising properties (Article 57(f)) - human health) |
Details | ||
|
AMINAZA TOLFAMATATE
|
418-350-1
|
-
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
Details | ||
|
243-072-0
|
19438-60-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
RSP Respiratory sensitising properties (Article 57(f)) - human health) |
Details | ||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
RSP Respiratory sensitising properties (Article 57(f)) - human health) |
Details | ||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
RSP Respiratory sensitising properties (Article 57(f)) - human health) |
Details | ||
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
Details | |||
|
HEXACONAZOLE
|
413-050-7
|
79983-71-4
|
Acute Tox. 4; Skin Sens. 1 |
Details | ||
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
Details | |||
|
show/hide
Platinate(2-), hexachloro-, (OC-6-11)-, dihydrogen, reaction products with 2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane
EC / List no:
271-555-6
| CAS no:
68585-32-0
Dihydrogen hexachloroplatinate, compound with 1,1,3,3-tetramethyl-1,3-divinyldisiloxane
EC / List no:
258-092-5
| CAS no:
52672-74-9
Platinate(2-), hexachloro-, dihydrogen, (OC-6-11)-, reaction products with palladium
EC / List no:
-
| CAS no:
68516-04-1
|
-
|
-
|
Acute Tox. 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
Details | ||
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
Details | |||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
Details | |||
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
Details | |||
|
show/hide
|
247-148-4
|
25637-99-4
|
Repr. 2; Lact. |
PBT Persistent, Bioaccumulative and Toxic (article 57d) |
Details | |
|
245-737-0
|
23560-59-0
|
Acute Tox. 3 |
Details | |||
|
203-838-7
|
111-14-8
|
Skin Corr. 1B |
Details | |||